BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21882901)

  • 1. Is pacemaker deactivation at the end of life unique? A case study and ethical analysis.
    Whitlock SN; Goldberg IP; Singh JP
    J Palliat Med; 2011 Oct; 14(10):1184-8. PubMed ID: 21882901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations for turning off pacemakers and defibrillators.
    Karches KE; Sulmasy DP
    Card Electrophysiol Clin; 2015 Sep; 7(3):547-55. PubMed ID: 26304534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
    Waterhouse E; Ahmad F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
    Mueller PS; Hook CC; Hayes DL
    Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pacemaker deactivation: withdrawal of support or active ending of life?
    Huddle TS; Amos Bailey F
    Theor Med Bioeth; 2012 Dec; 33(6):421-33. PubMed ID: 22351107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
    Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
    Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
    Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
    Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardiac defibrillators and end-of-life care--time for reflection, deliberation and debate?
    Sheehan M; Newton PJ; Stobie P; Davidson PM
    Aust Crit Care; 2011 Nov; 24(4):279-84. PubMed ID: 21676627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 10. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical issues on defibrillator deactivation in end-of-life patients.
    Facciorusso A; Stanislao M; Fanelli M; Valori VM; Valle G
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):498-500. PubMed ID: 21610508
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
    Morgenweck CJ
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.
    Padeletti L; Arnar DO; Boncinelli L; Brachman J; Camm JA; Daubert JC; Hassam SK; Deliens L; Glikson M; Hayes D; Israel C; Lampert R; Lobban T; Raatikainen P; Siegal G; Vardas P; ; Kirchhof P; Becker R; Cosio F; Loh P; Cobbe S; Grace A; Morgan J; ;
    Europace; 2010 Oct; 12(10):1480-9. PubMed ID: 20675674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.
    Kramer DB; Kesselheim AS; Brock DW; Maisel WH
    Heart Rhythm; 2010 Nov; 7(11):1537-42. PubMed ID: 20650332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical issues in end-of-life care.
    Hinshaw DB
    J Med Liban; 2008; 56(2):122-8. PubMed ID: 19534082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
    Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
    Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
    Pilkington BC
    J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is deactivation of artificial pacing and AICD illegal, immoral, and unethical?
    Silveira MJ
    Am J Geriatr Cardiol; 2003; 12(4):275-6. PubMed ID: 14619876
    [No Abstract]   [Full Text] [Related]  

  • 20. Deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Mitchell SL; Brock DW
    Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.